CLINICAL PERSPECTIVE

This Article Abstract Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Haïssaguerre, M. Articles by Jaïs, P. Search for Related Content PubMed PubMed Citation Articles by Haïssaguerre, M. Articles by Jaïs, P. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Hazardous Substances DB AMIODARONE HYDROCHLORIDE Medline Plus Health Information Atrial Fibrillation Related Collections Electrophysiology Ablation/ICD/surgery Arrhythmias, clinical electrophysiology, drugs

(Circulation. 2006;113:616-625.)
© 2006 American Heart Association, Inc.

Arrhythmia/Electrophysiology

Localized Sources Maintaining Atrial Fibrillation Organized by Prior Ablation

Michel Haïssaguerre, MD; Mélèze Hocini, MD; Prashanthan Sanders, MBBS, PhD; Yoshihide Takahashi, MD; Martin Rotter, MD; Frederic Sacher, MD; Thomas Rostock, MD; Li-Fern Hsu, MBBS; Anders Jonsson, MD; Mark D. O’Neill, MBChB, DPhil; Pierre Bordachar, MD; Sylvain Reuter, MD; Raymond Roudaut, MD; Jacques Clémenty, MD; Pierre Jaïs, MD

From the Hôpital Cardiologique du Haut-Lévêque and University Victor Segalen, Bordeaux, France.

Correspondence to Professor Michel Haïssaguerre, Hôpital Cardiologique du Haut-Lévêque, Avenue de Magellan, 33604 Bordeaux, France. E-mail jacques.clementy{at}pu.u-bordeaux2.fr

Received March 2, 2005; revision received November 10, 2005; accepted November 18, 2005.

	Abstract

Top Abstract Introduction Methods Results Discussion References

 
Background— Endocardial mapping of localized sources driving atrial fibrillation (AF) in humans has not been reported.

Methods and Results— Fifty patients with AF organized by prior pulmonary vein and linear ablation were studied. AF was considered organized if mapping during AF showed irregular but discrete atrial complexes exhibiting consistent activation sequences for >75% of the time using a 20-pole catheter with 5 radiating spines covering 3.5-cm diameter or sequential conventional mapping. A site or region centrifugally activating the remaining atrial tissue defined a source. During AF with a cycle length of 211±32 ms, activation mapping identified 1 to 3 sources at the origin of atrial wavefronts in 38 patients (76%) predominantly in the left atrium, including the coronary sinus region. Electrograms at the earliest area varied from discrete centrifugal activation to an activity spanning 75% to 100% of the cycle length in 42% of cases, the latter indicating complex local conduction or a reentrant circuit. A gradient of cycle length (>20 ms) to the surrounding atrium was observed in 28%. Local radiofrequency ablation prolonged AF cycle length by 28±22 ms and either terminated AF or changed activation sequence to another organized rhythm. In 4 patients, the driving source was isolated, surrounded by the atrium in sinus rhythm, and still firing at high frequency (228±31 ms) either permanently or in bursts.

Conclusions— AF associated with consistent atrial activation sequences after prior ablation emanates mostly from localized sources that can be mapped and ablated. Some sources harbor electrograms suggesting the presence of localized reentry.

Key Words: ablation • arrhythmia • atrial flutter • mapping • tachyarrhythmias

	Introduction

Top Abstract Introduction Methods Results Discussion References

 
Curing atrial fibrillation (AF) through surgical or catheter ablation is based on the elimination of the initiating triggers and/or the maintaining substrate.^1–6 The most widely accepted mechanism for maintaining AF has been multiple reentrant wavelets.^1,7–9 However, observations of a relative degree of organization with transient linking of successive fibrillatory wavefronts and spatiotemporal periodicity emanating from discrete sites of high-frequency activity with frequency gradient to the surrounding tissue have implicated the potential role of localized sources.^10–13 Direct mapping for a "source" has been demonstrated in experimental models^12,14 and suggested during intraoperative mapping in humans^15–17; the latter studies, however, were limited to accessible epicardial parts of atria, and mapping-directed ablation was attempted in only a few cases. Endocardial activation mapping of stable sources maintaining AF has not been reported in humans. We hypothesized that AF exhibiting discrete atrial complexes and consistent activation sequence may be maintained by such sources that can be characterized and ablated.

Clinical Perspective p 625

	Methods

Top Abstract Introduction Methods Results Discussion References

 
Study Population
The study comprised 50 consecutive patients with organized AF occurring after prior ablation, including pulmonary vein (PV) isolation, cavotricuspid isthmus ablation, and left atrial (LA) linear ablation in the majority (at the LA roof joining the 2 superior PVs and/or the isthmus between the left inferior PV and mitral annulus). Organized AF was defined by endocardial mapping during AF displaying (1) irregular atrial cycle with beat-to-beat variations of 20 ms; (2) dominantly discrete atrial complexes with a consistent activation sequence for >75% of the time using catheters sequentially positioned at the right free wall, left anterior wall, and the coronary sinus (CS); and (3) the stability of activation evaluated over a 10-minute period of spontaneous or induced AF.

These patients represented 17% of 295 patients with persistent or recurrent AF after prior ablation. The procedural end point for the above ablation was electrical isolation of the PV and linear conduction block.

All patients gave written informed consent to participate in the study, which involved the use of an investigational catheter for mapping, and the protocol was approved by the institutional Clinical Research and Ethics Committee.

Electrophysiological Study
All antiarrhythmics, except for amiodarone (n=10), were ceased 5 half-lives before ablation. Oral anticoagulation was administered (target international normalized ratio, 2 to 3) for at least 1 month before the procedure, and transesophageal echocardiography was performed within 5 days of the procedure to exclude atrial thrombus.

Surface ECG and bipolar endocardial electrograms were continuously monitored and stored on a computer-based digital amplifier/recorder system (Bard Electrophysiology). Intracardiac electrograms were filtered from 30 to 500 Hz.

The following catheters were introduced via the right femoral vein for electrophysiological study: (1) A steerable quadripolar catheter (5-mm electrode spacing, Xtrem, ELA Medical) was positioned as a reference in the right or left appendage or within the CS with the proximal electrode positioned at 4 to 5 o’clock along the mitral annulus in the left anterior oblique projection; (2) a 20-pole steerable mapping catheter arranged in 5 soft radiating spines (1-mm electrodes separated by 4-, 4-, and 4-mm interelectrode spacing) covering a diameter of 3.5 cm (PentaRay, Biosense-Webster) was introduced via a long sheath (Preface Multipurpose, Biosense-Webster) that was continuously perfused with heparinized glucose and left in the LA or right atrium; and (3) an irrigated-tip quadripolar ablation catheter with a distal 3.5-mm tip and then three 1-mm electrodes separated by 2, 5, and 2 mm (Thermocool, Biosense-Webster) also was used. After transseptal puncture, a single bolus of 50 IU/kg heparin was administered and repeated only for procedures lasting 4 hours.

Study Protocol
In all patients, an initial evaluation was performed of the PVs to determine the presence of conduction recovery. If PV-LA conduction was present, isolation was performed. In patients in sinus rhythm, linear lesions were evaluated and reablated if required.

Mapping of AF
Activation mapping was performed during organized AF to identify potential sources maintaining AF. The term "source" is used in a broad sense to indicate the origin of atrial wavefronts during AF without inferring its mechanism (focal or reentrant) or size (discrete or wide). A source was localized by step-by-step evaluation of atrial activation. The 20-pole catheter was used to identify the direction of activation by comparing the precocity of electrograms of the 5 limbs during AF relative to the reference electrogram (Figures 1 and 2A). The catheter was moved gradually in the direction of earliest activity until a site showing the earliest possible activity or an area centrifugally propagating to the surrounding atria was reached. An attempt was made to localize the source at the center of mapping field to obtain activation spreading from internal to external bipoles (Figure 2A, left). It was sometimes necessary to examine the order of activities during the longest atrial cycles to confirm their sequence. The lateral parts of the LA (facing the transseptal access) were easily mapped by the multilimb catheter, whereas the medial and septal parts required a 90° to 180° curvature, and sometimes all the spines could not be applied to the endocardial tissue simultaneously. When the sources originated from the most inferior part of the atria, signified by an inferior-to-superior direction of atrial activation, the multilimb catheter could not reach or stabilize along the tricuspid and mitral annuli and was replaced by the quadripolar ablation catheter. The latter was dragged along the endocardial inferior LA by looping the catheter to be positioned parallel to the CS catheter.

View larger version (49K): [in this window] [in a new window]   Figure 1. Activation mapping using the multispine catheter. Atria were mapped by progressively moving the catheter to identify the earliest site of activity (*), as demonstrated in the 2 sequential panels. In this case, endocardial activity has been determined relative to the catheter positioned in the CS at the bottom.

View larger version (42K): [in this window] [in a new window]   Figure 2. A, Two examples of activation mapping at the source location showing either discrete site of early activation (mean cycle length, 188 ms; bipole D15–16 on the left) or area of prolonged electrograms spanning all the cycle length (mean cycle length, 200 ms; right panel) contiguous to isolated right superior PV (bipoles A and B). The percentage of cycle length covered by local electrograms is 36% and 100%, respectively. Left, The earliest site can be defined within the mapping field with activation spreading from internal (3–4, 7–8, 11–12, 15–16, 19–20) to external bipoles (1–2, 5–6, 9–10, 13–14, 17–18) (before spreading to the surrounding atria). Right, In contrast, the earliest site cannot be defined within the mapping field (however, the remaining atria is activated centrifugally from this area). B, Electrograms at the ablation site. Left, Alternating electrical activity between proximal and distal bipoles of the ablation catheter (arrows), potentially indicating a rotating wave. Middle, Distal-to-proximal activation sequence. Right, Synchronous activation.

Analysis of Electrograms at the Earliest Site
The percentage of AF cycle length covered by an electrical activity at the earliest site was determined by adding the duration of all asynchronous electrograms and was expressed as a function of the mean AF cycle length duration. The cycle length of the source was calculated by averaging 10 consecutive cycles having an identical activation sequence. A frequency gradient around the atrial source was considered to be present if the surrounding LA had a 20-ms-longer cycle length demonstrated within the 20-pole mapping field. A frequency gradient in the CS region was evaluated by comparing local CS cycles and adjacent inferior LA (&2 cm around using quadripolar catheters). In addition, the electrograms at the earliest site recorded by the ablation catheter were analyzed during the 4 seconds before ablation to evaluate the following characteristics: electrogram morphology separated into consistent (similar complexes) or inconsistent (varying complexes); electrogram duration measured from the beginning to end of the local electrogram averaged over 10 consecutive complexes and at the shortest and longest cycle lengths; and if the proximal bipole had adequate tissue contact at the ablation site, the relative activation timing between distal and proximal bipoles (from electrogram onset to onset) separated into 3 categories (Figure 2B) as synchronous activation, distal-to-proximal activation (proximal electrogram starting before the end of distal one), or alternating activation (no overlapping between the distal and proximal electrograms).

Inducibility of AF
AF inducibility was evaluated by burst atrial pacing (5-second bursts at an output of 20 mA and a pulse width of 2 ms) from the mid CS and the right atrial and LA appendage (in random order), beginning at a cycle length of 250 ms and reducing at 10-ms intervals until atrial refractoriness. AF was considered inducible if it persisted for 10 minutes. If AF terminated after <10 minutes, induction was repeated at least 3 times from each of the 3 sites.

AF was defined by the beat-to-beat variability in cycle length, in contrast to atrial tachycardia, which was defined as a rapid regular atrial rhythm with stable cycle length, morphology, and activation sequence. A macroreentrant mechanism was defined by recording of the entire cycle length of activity in 1 chamber, with entrainment at 2 points (separated by 2 cm) demonstrating a postpacing interval <20 ms longer than the tachycardia cycle length.

The AF cycle length was determined within the CS or LA appendage before ablation by averaging 30 consecutive cycles using automated cycle length monitoring software (Bard Electrophysiology). Interelectrogram intervals of <100 ms were counted as a single interval. At each time point, the automated annotation was manually verified and corrected with online calipers at a paper speed of 100 mm/s.

Radiofrequency Ablation
Radiofrequency (RF) energy was delivered with a power of 35 W in the atrial tissue using irrigation rates of 5 to 60 mL/min (0.9% saline via Cool Flow; Biosense-Webster) for a duration of 60 to 240 seconds at the site or area of earliest activity. The multispine catheter was left in position throughout the ablation procedure if it was stable and was withdrawn if unstable. RF energy was delivered with a power of 25 to 30 W along the venous structures using multiple applications. Temperature was limited to 50°C. Successful ablation of the source was demonstrated by the termination of AF to sinus rhythm or a change in cycle length and activation sequence (conversion to another rhythm).

Follow-Up
After ablation, patients received subcutaneous heparin while oral anticoagulation was reinitiated. All patients had at least 3 days of ambulatory monitoring in hospital during this time. Amiodarone was ceased in all patients. Other antiarrhythmic drugs were ceased in paroxysmal AF and continued for 1 to 2 months in persistent AF.

Patients were hospitalized for 1 day at 1, 3, 6, and 12 months after the last procedure for assessment, including transthoracic echocardiography and ambulatory monitoring. Stress testing was performed at 3 months. At 12 months, all patients underwent CT angiography to exclude PV stenosis. If patients maintained sinus rhythm for 3 months, cessation of anticoagulation was considered. In the event of recurrence of AF or ectopy, patients were offered further ablation or trial of antiarrhythmics. A successful outcome was defined as the absence of arrhythmia (AF or flutter) beyond the second month.

Statistical Analysis
All variables are reported as mean±SD. Comparison between groups was performed with the Student t test or the Wilcoxon signed-rank test. Statistical significance was established at P<0.05.

	Results

Top Abstract Introduction Methods Results Discussion References

 
Mapping during organized AF showed temporally stable and consistent activation sequence emanating from a localized site/area in 38 patients, whereas in 12 patients, AF became disorganized (inconsistent activation sequences) during mapping. Characteristics of these 38 patients are presented in the Table. The mean AF cycle length measured in the CS was 211±32 ms.

View this table: [in this window] [in a new window]   Baseline Characteristics

AF was mapped during the index procedure after PV and linear ablation in 15 patients; prior AF ablation was performed 11±12 months before in 23 patients (with AF being spontaneously present in 6 and induced in 17 at the second procedure). PV isolation had been performed in all patients using total RF delivery of 39±16 minutes, which included applications targeting residual fractionated potentials (electrograms with 2 deflections over 50 ms) at the PV orifices (typically 1 to 2 minutes per PV). Complete linear block had been achieved in 27 patients, producing activation detours of 155±39 and 168±24 ms after RF delivery of 10±4 and 21±10 minutes at the roof and mitral isthmus, respectively.

Anatomic Location of Sources
One, 2, and 3 separate sources were identified in 30, 5, and 3 patients, respectively, at a total of 49 different locations (Figure 3). These sources were identified sequentially during ablation, which produced either termination of AF or a change in activation sequence mapped to either another source or a macroreentrant flutter (Figure 4). CS activation associated with these sources was proximal to distal in 30 cases, distal to proximal in 14 cases, and synchronous or varying in 5 cases. Thirty-six sources originated from the atrial tissue: in the anterior LA (n=6); along the collar/root of the left appendage (n=3); in the posterior LA, including 8 in proximity with previously ablated PVs (n=11); around the fossa ovalis (n=4); at the LA roof (n=5); from other regions (n=4); and from the right atrium (n=3; lateral wall, cavotricuspid isthmus, anterior wall). The sources originated from the CS region in 13 patients and were localized using quadripolar mapping catheters.

View larger version (29K): [in this window] [in a new window]   Figure 3. Schematic demonstrating the distribution of sources of AF. The LA roof is indicated by the region between the 2 dotted lines. Shaded areas indicate the isolated PV.

View larger version (15K): [in this window] [in a new window]   Figure 4. Schematic representation of the sequence of ablation and results.

Local Electrogram Characteristics
In the 36 atrial sources, at the site of earliest activation, localized multielectrode maps showed a discrete site harboring local electrograms for <75% of the cycle length in 21 (58%) (Figure 2A, left). Electrical activity covering 75% to 100% of the cycle length was observed in 15 patients (42%), suggesting localized complex activation or a small circuit in this area (Figure 2A, right). Entrainment maneuvers could not be performed because of cycle length variations during AF.

In 13 CS region sources, the earliest discrete activity could be identified at the rim of CS ostium in 2 or within the CS with a later activation of the immediately proximal and distal CS in 6 (Figure 5); in 5, the activation origin was inferred to originate from the initial 3 cm of the CS on the basis of later activation of all surrounding areas (septum, inferior LA, and distal CS). In the latter cases, a discrete early activation could not be identified because contiguous endocardial and epicardial sites showed alternating earliest activity, with rapid bursts resulting in an uninterrupted electrical activity in this region.

View larger version (27K): [in this window] [in a new window]   Figure 5. Electrograms showing centrifugal activation within the CS during AF of 78 minutes duration. RF ablation at the site of earliest activity terminated AF in 34 seconds.

The mean, shortest, and longest cycle lengths of the source were 196±47, 165±44, and 226±46 ms, varying by 59±37 ms at each individual location. There was 1:1 propagation from the source to the surrounding atrium in 35, whereas there was a gradient frequency >20 ms (44±27 ms) in 14 cases (28%; Figure 6). The cycle length was shorter at sites displaying a frequency gradient than in those with 1/1 propagation; mean cycle length was 165±39 versus 210±38 ms (P=0.0015), and shortest cycle length was 126±21 versus 179±39 ms (P<0.0001). There was no significant difference in the cycle length of sources located within the CS region and those at other atrial sites.

View larger version (33K): [in this window] [in a new window]   Figure 6. Gradient of high-frequency activity recorded in the posterior LA. In both, the bipole A3–4 demonstrates the most rapid activity. Left, Activity at bipole A3–4 has a mean cycle length of 126 ms; the immediately surrounding bipoles are much slower, with a mean cycle length of 214 ms. Right, The activity in A3–4 is faster and/or split with the surrounding local activity having a cycle length of 144 ms.

At the ablation site, the electrograms showed a consistent morphology in all but 3 cases. Their mean duration was 76±40 ms (range, 25 to 200 ms), prolonged at shortest AF cycle lengths (97±34 ms; P=0.0015), and shortened at the longest cycle lengths (48±17 ms; P=0.0015). The mean electrogram duration was >100 ms in 10 locations (20%).

Simultaneous distal and proximal (at 5-mm distance) recordings were available in 38 cases at the ablation site. The distal recording preceded proximal activity in 18, was synchronous in 4, and demonstrated a gradient in activation time, producing an alternate distal/proximal activity in 16 (42%).

Patients taking amiodarone had a longer initial AF cycle length than patients without amiodarone (215±51 versus 194±36 ms; P=0.06) but no difference in electrogram duration at the source origin.

RF Ablation
RF delivery resulted in termination of AF (Figure 7) or conversion to a new arrhythmia associated with a different activation sequence (Figure 4) confirmed to be due to another source or macroreentry. Conversion to AF originating from another source was associated with a 31±16-ms increase in cycle length.

View larger version (64K): [in this window] [in a new window]   Figure 7. Centrifugal activation recorded on the multispine catheter at the top of posterior LA (fluoroscopic image on the right bottom), with spine C demonstrating the earliest activity (*) in AF that had been sustained for 32 minutes. Right top, Ablation at this site with termination of AF 10 seconds after the beginning of ablation.

For atrial sources, the duration of RF application to achieve termination or conversion of AF was 97±90 seconds (median, 60 seconds; range, 5 to 360 seconds). A single patient with multifocal ectopy from an LA appendage required multiple RF applications (up to 360 seconds), which resulted in inadvertent disconnection of the appendage. Atrial sources originating from the roof were adjacent to a prior ablation line in 4 of 5 patients.

CS sources were initially approached from the endocardial inferior LA in 6 patients (including the 5 without discrete early activation) by dragging along the mitral annulus. The delivery of 5±2 minutes of RF energy resulted in slowing of CS activity in 5 and local abolition of CS potentials in 1 (Figure 8); AF terminated to sinus rhythm in 2 patients (within 3 minutes of RF) and persisted in 4 patients. Ablation was begun within the CS in the remaining 7 patients; in the abovementioned 4, it followed unsuccessful endocardial ablation. Ablation limited to the ostium in 2 patients resulted in AF termination in <1 minute. In 9 patients, RF was delivered within the first 3 cm of the CS and resulted in arrhythmia termination: within 1 minute in 4 patients and after more prolonged applications (up to 5 minutes) in 5 patients. The mean duration of RF application to achieve termination or conversion of AF was 106±81 seconds (median, 60 seconds; range, 5 to 300 seconds). CS angiogram after ablation showed a diameter of <5 mm in 1 of 8 patients.

View larger version (43K): [in this window] [in a new window]   Figure 8. Termination of AF after elimination of local CS potentials. In this case, endocardial ablation for 300 seconds using a looped catheter facing the CS catheter resulted in a slowing and loss of CS potentials (* on top) followed by a dissociated beat (* on bottom) and termination of AF.

In the whole group, before termination, RF ablation resulted in an increase in AF cycle length of 28±22 ms. In 14 cases, the termination of AF was "heralded" by an abrupt slowing (pauses >300 ms) in LA activity during the last 30 seconds. In 4 patients, RF ablation organized AF to a regular atrial tachycardia (originating from the same location) before termination. During ablation, there was a single instance (at CS ostium) of sudden bradycardia of >3 seconds, indicating a vagal effect. The total RF delivery per location was 5±2 minutes (range, 1 to 8 minutes). The total fluoroscopic and procedural durations were 62±28 and 212±88 minutes, respectively.

Additional Ablation
A total of 5 patients had spontaneous conversion to macroreentrant flutter after elimination of a single source, and an additional 7 patients had inducible sustained flutter. Of these 12, 6 had undergone no prior linear ablation, and 6 had a single prior line. Mapping demonstrated macroreentry around the right PVs (n=5), perimitrally (n=6), or a combination of both (n=1). They underwent RF ablation of the roof, mitral isthmus, or both, respectively.

There were 2 adverse effects: dissociation of LA appendage activity and a cerebral vascular accident 3 hours after the ablation procedure in another patient. At the end of the procedure, AF or atrial flutter was not inducible in 31 patients (82%), whereas 7 patients had inducible AF that displayed complex activation sequences and electrograms.

Isolated Focal Sources
In 4 patients, the area containing the source was inadvertently isolated, being recorded in a discrete point in 2 (1 each in the anterior LA and posterior LA) and along 2 adjacent bipoles in 2 (LA roof and CS). These islands were contiguous with either prior linear ablation in 3 or a surgical atriotomy in 1. The isolated area was surrounded by atrial tissue in sinus rhythm and showed persistent fibrillatory activity with a local cycle length of 228±31 ms (varying from 110 to 270 ms). The local activity within these fibrillating regions showed discrete electrograms in 3 or prolonged and alternating fractionated complexes in 1 (Figure 9). The isolated sources fired continuously in 2 patients and in bursts lasting 2 to 15 seconds in 2. In patients with continuous activity, the source abruptly ceased firing 8 minutes after isolation in 1 (and could not be reproduced by local pacing), whereas firing persisted in 1 case when remapped 5 days later.

View larger version (28K): [in this window] [in a new window]   Figure 9. Persistent firing from isolated sources with the atria maintained in sinus rhythm. A, Top, Prolonged, fractionated, and alternating activity in the roof with a mean cycle length of 250 ms. Bottom, Ongoing burst of activity with discrete electrograms having a mean cycle length of 200 ms, ranging from 110 to 270 ms within the isolated CS. Note the variation in electrogram morphology in both panels and of the activation sequence in the top, suggesting changing activation within the area. B, Isolated source firing in the anterior LA. All 3 panels are from the same patient separated by a few seconds and demonstrate the differing rates of firing with discrete electrograms. Note that the electrograms demonstrate also the activity of the surrounding atria (coincident with the onset of the P wave) that is in sinus rhythm.

Follow-Up
Early after ablation, 4 patients had recurrent AF or atrial flutter. Ablation was performed for foci triggering AF (1 in the superior vena cava and 1 in the CS ostium), recovery of PV conduction in 3, and a gap in the LA line in 1.

At 8±3 months of follow-up, 31 patients (82%) were arrhythmia free, including 26 without the use of antiarrhythmics. No patient, including those with CS ablation, developed clinical symptoms of coronary artery disease or ischemic features during exercise test 3 months after ablation.

	Discussion

Top Abstract Introduction Methods Results Discussion References

 
This study demonstrates that AF organized by prior ablation and associated with consistent atrial activation sequences is maintained predominantly by localized sources that can be mapped and ablated. Such sources demonstrate heterogeneous electrophysiological characteristics and varied from discrete early activity to complex local activity spanning most of the cycle length, suggesting different underlying mechanisms.

Mapping of Sources Maintaining AF
Patients were selected on the basis of organized AF displaying discrete electrograms⁸ and with a consistent activation sequence. These patients represented 17% of our patients with persistent or recurrent AF after prior ablation. Sources were identified by mapping atrial activation to localize the area with centrifugal propagation spreading to the surrounding atrium. This could be evidenced by either simultaneous local high-density multielectrode mapping or sequential conventional mapping. Their role in maintaining AF was confirmed by prolongation of the AF cycle length and a change in atrial activation sequence or AF termination during RF delivery.

The sources were observed to discharge continuously or in bursts and demonstrated varying cycle lengths. Their intrinsic properties were strikingly evidenced independently of external influence in patients with islands of fibrillatory activity isolated by ablation. Driving sources with such a spectrum of spontaneous activity maintaining AF have not been described previously in humans.

Although the exact arrhythmia mechanism could not be ascertained from the clinical electrophysiological data, the electrogram recordings indicate that some sources were discrete foci spreading rapidly from the internal to external electrodes within the mapping field, whereas in 42% of cases, local reentry was suggested by prolonged electrograms spanning most of the cycle length or by alternating activation at adjacent sites. The latter observation indicates the presence of a local intervening arc of block⁸; however, we could not distinguish whether this activation gradient resulted from asynchronous independent wavefronts or sequential activation of rotating waves. A rotating wave would be compatible with prior mapping studies of leading circle reentry in the rabbit¹⁸ or rotors in sheep,¹² which reported wavelengths of 6 to 8 mm and 10±3 mm, respectively, both of which should be identifiable within the spatial resolution of the presently used electrode spacing. Similar electrograms using the same high-density catheter during atrial tachycardia after AF ablation have been demonstrated with entrainment supporting a small circuit or rotor.¹⁹

Stable sources as a mechanism maintaining AF have been reported in few studies compared with the large amount of literature demonstrating the role of wandering wavelets or closed-loop reentry.^1,8,9,20 Either automatic foci or small rapid circuits (rotors) have been reported during acetylcholine-induced AF,^14,18,21 in chronic pacing-induced AF,²² and in computer simulation models of AF.²³

Anatomic Location of Sources
In our patients, sources maintaining AF were widely distributed in the LA with some clustering along the CS–LA interface, the anterior LA, and the LA appendage; these regions were distinct from those commonly involved in ablation strategies. The clustering at anatomic regions of structural discontinuities suggests the arrhythmogenic role of heterogeneous fiber properties favoring anatomic reentry or anchoring rotors^21,22 or the uninterrupted interaction between contiguous structures to maintain AF, notably along the CS. In humans, intraoperative mapping studies that were spatially constrained by epicardial access have provided data indicating a localized substrate maintaining AF. Rapid repetitive activations were identified from the PV, the region lateral to the left PV, the "corners" of the posterior LA, the LA appendage, the CS, and occasionally the lateral right atrium.^{13,15,17,24–28}

Clinical Implications
The present study supports the notion that ectopic sources have an important role in the maintenance of AF, in addition to the PV and wavelets/reentrant loops. These sources are responsible in part for recurrent AF occurring after PV isolation and complete linear lesions, with their ablation being the last necessary step of substrate elimination, confirmed by the noninducibility of arrhythmia and clinical outcome in most patients.

Converging on the origin of atrial activation provided important information for their recognition. Prolonged or alternating (in contiguous electrodes) electrograms covering most of the cycle length may correspond to localized circuit or rotor. In some cases, the source harbored localized high-frequency potentials; in most, 1/1 atrial propagation rendered activation mapping indispensable in localizing the origin of wavefronts, highlighting the complementary role of techniques using frequency or activation mapping.

Study Limitations
In this cohort, mapping was facilitated by prior ablation, resulting in a relatively stable atrial activation and allowing identification of the earliest site. Whether a similar phenomenon could be identified in more complex forms of AF in the broader AF population is unknown. However, the method described based on identifying epochs of centrifugal activation provides a paradigm applicable to these conditions, possibly assisted by 3D signal analysis techniques and means to organize AF.

The information from local electrograms at the site of activation origin could not be evaluated in terms of specificity or predictive value for ablation. In addition, some of the complex signals may have resulted from prior ablation.

Finally, the safety of these procedures may be a concern, particularly when repeated ablation is required within the CS. In this series, there were no instance of hemopericardium, CS thrombosis, or clinically apparent side effects on the circumflex artery; however, the long-term impact of such ablation is unknown. In the patient in whom the left appendage was isolated, long-term anticoagulation is probably mandatory.

	Acknowledgments

 
Dr Sanders is supported by the Neil Hamilton Fairley Fellowship from the National Health and Medical Research Council of Australia and the Ralph Reader Fellowship from the National Heart Foundation of Australia. Dr Rotter is supported by the Swiss National Foundation for Scientific Research, Bern, Switzerland. Dr Rostock is supported by the German Cardiac Society. Dr Jonsson is supported by the Swedish Cardiac Society. Dr O’Neill is supported by the British Heart Foundation.

Disclosures

PentaRay catheters were developed and provided by Biosense-Webster. Drs Sanders, Jais, and Haissaguerre report having served on the advisory boards of and having received lecture fees from Biosense-Webster and Bard Electrophysiology. Drs Rotter and Hsu report having received lecture fees from Biosense-Webster. The other authors report no conflicts.

	References

Top Abstract Introduction Methods Results Discussion References

 
1. Cox JL, Canavan TE, Schuessler RB, Cain ME, Lindsay BD, Stone C, Smith PK, Corr PB, Boineau JP. The surgical treatment of atrial fibrillation, II: intraoperative electrophysiologic mapping and description of the electrophysiologic basis of atrial flutter and atrial fibrillation. J Thorac Cardiovasc Surg. 1991; 101: 406–426.[Abstract]

2. Haissaguerre M, Jais P, Shah DC, Takahashi A, Hocini M, Quiniou G, Garrigue S, Le Mouroux A, Le Metayer P, Clementy J. Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins. N Engl J Med. 1998; 339: 659–666.[Abstract/Free Full Text]

3. Chen SA, Hsieh MH, Tai CT, Tsai CF, Prakash VS, Yu WC, Hsu TL, Ding YA, Chang MS. Initiation of atrial fibrillation by ectopic beats originating from the pulmonary veins: electrophysiological characteristics, pharmacological responses, and effects of radiofrequency ablation. Circulation. 1999; 100: 1879–1886.[Abstract/Free Full Text]

4. Pappone C, Rosanio S, Augello G, Gallus G, Vicedomini G, Mazzone P, Gulletta S, Gugliotta F, Pappone A, Santinelli V. Mortality, morbidity, and quality of life after circumferential pulmonary vein ablation for atrial fibrillation: outcomes from a controlled nonrandomized long-term study. J Am Coll Cardiol. 2003; 42: 185–197.[Abstract/Free Full Text]

5. Marrouche NF, Martin DO, Wazni O, Gillinov AM, Klein A, Bhargava M, Saad E, Bash D, Yamada H, Jaber W, Schweikert R, Tchou P, Abdul-Karim A, Saliba W, Natale A. Phased-array intracardiac echocardiography monitoring during pulmonary vein isolation in patients with atrial fibrillation: impact on outcome and complications. Circulation. 2003; 107: 2710–2716.[Abstract/Free Full Text]

6. Oral H, Knight BP, Ozaydin M, Chugh A, Lai SW, Scharf C, Hassan S, Greenstein R, Han JD, Pelosi F Jr, Strickberger SA, Morady F. Segmental ostial ablation to isolate the pulmonary veins during atrial fibrillation: feasibility and mechanistic insights. Circulation. 2002; 106: 1256–1262.[Abstract/Free Full Text]

7. Moe GK. On the multiple wavelet hypothesis of atrial fibrillation. Arch Int Pharmacodyn Ther. 1962; 140: 183–188.

8. Konings KT, Kirchhof CJ, Smeets JR, Wellens HJ, Penn OC, Allessie MA. High-density mapping of electrically induced atrial fibrillation in humans. Circulation. 1994; 89: 1665–1680.[Abstract/Free Full Text]

9. Wang Z, Page P, Nattel S. Mechanism of flecainide’s antiarrhythmic action in experimental atrial fibrillation. Circ Res. 1992; 71: 271–287.[Abstract/Free Full Text]

10. Gerstenfeld EP, Sahakian AV, Swiryn S. Evidence for transient linking of atrial excitation during atrial fibrillation in humans. Circulation. 1992; 86: 375–382.[Abstract/Free Full Text]

11. Sih HJ, Zipes DP, Berbari EJ, Adams DE, Olgin JE. Differences in organization between acute and chronic atrial fibrillation in dogs. J Am Coll Cardiol. 2000; 36: 924–931.[Abstract/Free Full Text]

12. Mandapati R, Skanes A, Chen J, Berenfeld O, Jalife J. Stable microreentrant sources as a mechanism of atrial fibrillation in the isolated sheep heart. Circulation. 2000; 101: 194–199.[Abstract/Free Full Text]

13. Jais P, Haissaguerre M, Shah DC, Chouairi S, Gencel L, Hocini M, Clementy J. A focal source of atrial fibrillation treated by discrete radiofrequency ablation. Circulation. 1997; 95: 572–576.[Abstract/Free Full Text]

14. Schuessler RB, Grayson TM, Bromberg BI, Cox JL, Boineau JP. Cholinergically mediated tachyarrhythmias induced by a single extrastimulus in the isolated canine right atrium. Circ Res. 1992; 71: 1254–1267.[Abstract/Free Full Text]

15. Sahadevan J, Ryu K, Peltz L, Khrestian CM, Stewart RW, Markowitz AH, Waldo AL. Epicardial mapping of chronic atrial fibrillation in patients: preliminary observations. Circulation. 2004; 110: 3293–3299.[Abstract/Free Full Text]

16. Todd DM, Skanes AC, Guiraudon G, Guiraudon C, Krahn AD, Yee R, Klein GJ. Role of the posterior left atrium and pulmonary veins in human lone atrial fibrillation: electrophysiological and pathological data from patients undergoing atrial fibrillation surgery. Circulation. 2003; 108: 3108–3114.[Abstract/Free Full Text]

17. Nitta T, Ishii Y, Miyagi Y, Ohmori H, Sakamoto S, Tanaka S. Concurrent multiple left atrial focal activations with fibrillatory conduction and right atrial focal or reentrant activation as the mechanism in atrial fibrillation. J Thorac Cardiovasc Surg. 2004; 127: 770–778.[Abstract/Free Full Text]

18. Allessie MA, Bonke FI, Schopman FJ. Circus movement in rabbit atrial muscle as a mechanism of tachycardia, II: the role of nonuniform recovery of excitability in the occurrence of unidirectional block, as studied with multiple microelectrodes. Circ Res. 1976; 39: 168–177.[Abstract/Free Full Text]

19. Sanders P, Hocini M, Jais P, Hsu LF, Takahashi Y, Rotter M, Scavee C, Pasquie JL, Sacher F, Rostock T, Nalliah CJ, Clementy J, Haissaguerre M. Characterization of focal atrial tachycardia using high-density mapping. J Am Coll Cardiol. 2005; 46: 2088–2099.[Abstract/Free Full Text]

20. Kumagai K, Khrestian C, Waldo AL. Simultaneous multisite mapping studies during induced atrial fibrillation in the sterile pericarditis model: insights into the mechanism of its maintenance. Circulation. 1997; 95: 511–521.[Abstract/Free Full Text]

21. Jalife J, Berenfeld O, Mansour M. Mother rotors and fibrillatory conduction: a mechanism of atrial fibrillation. Cardiovasc Res. 2002; 54: 204–216.[Abstract/Free Full Text]

22. Morillo CA, Klein GJ, Jones DL, Guiraudon CM. Chronic rapid atrial pacing: structural, functional, and electrophysiological characteristics of a new model of sustained atrial fibrillation. Circulation. 1995; 91: 1588–1595.[Abstract/Free Full Text]

23. Kneller J, Zou R, Vigmond EJ, Wang Z, Leon LJ, Nattel S. Cholinergic atrial fibrillation in a computer model of a two- dimensional sheet of canine atrial cells with realistic ionic properties. Circ Res. 2002; 90: E73–E87.[CrossRef][Medline] [Order article via Infotrieve]

24. Harada A, Konishi T, Fukata M, Higuchi K, Sugimoto T, Sasaki K. Intraoperative map guided operation for atrial fibrillation due to mitral valve disease. Ann Thorac Surg. 2000; 69: 446–451.[Abstract/Free Full Text]

25. Wu TJ, Doshi RN, Huang HL, Blanche C, Kass RM, Trento A, Cheng W, Karagueuzian HS, Peter CT, Chen PS. Simultaneous biatrial computerized mapping during permanent atrial fibrillation in patients with organic heart disease. J Cardiovasc Electrophysiol. 2002; 13: 571–577.[CrossRef][Medline] [Order article via Infotrieve]

26. Nair M, Shah P, Batra R, Kumar M, Mohan J, Kaul U, Arora R. Chronic atrial fibrillation in patients with rheumatic heart disease: mapping and radiofrequency ablation of flutter circuits seen at initiation after cardioversion. Circulation. 2001; 104: 802–809.[Abstract/Free Full Text]

27. Olgin JE, Jayachandran JV, Engesstein E, Groh W, Zipes DP. Atrial macroreentry involving the myocardium of the coronary sinus: a unique mechanism for atypical flutter. J Cardiovasc Electrophysiol. 1998; 9: 1094–1099.[Medline] [Order article via Infotrieve]

28. Haissaguerre M, Marcus FI, Fischer B, Clementy J. Radiofrequency catheter ablation in unusual mechanisms of atrial fibrillation: report of three cases. J Cardiovasc Electrophysiol. 1994; 5: 743–751.[Medline] [Order article via Infotrieve]

---

 

CLINICAL PERSPECTIVE

The most widely accepted mechanism for the maintenance of AF has been multiple reentrant wavelets or loops. However, it is being increasingly suggested that localized sources of activity may have a role in the maintenance of AF. To date, direct mapping evidence of a localized source has been demonstrated only in experimental models. This clinical study demonstrates that after AF became organized (by ablation around PVs and selected other sites), further mapping could identify localized sources maintaining AF where ablation then terminated AF. These sources were characterized as discrete foci or areas of small reentrant activity (potentially "rotors"). It is hoped that recognition and ablation of localized sources may lead to further improvement in the success of AF ablation, particularly in patients with chronic AF.

This article has been cited by other articles:

				G. Niu, B. J. Scherlag, Z. Lu, M. Ghias, Y. Zhang, E. Patterson, T. W. Dasari, S. Zacharias, R. Lazzara, W. M. Jackman, et al. An Acute Experimental Model Demonstrating 2 Different Forms of Sustained Atrial Tachyarrhythmias Circ Arrhythm Electrophysiol, August 1, 2009; 2(4): 384 - 392. [Abstract] [Full Text] [PDF]

				M. A. Crandall, D. J. Bradley, D. L. Packer, and S. J. Asirvatham Contemporary Management of Atrial Fibrillation: Update on Anticoagulation and Invasive Management Strategies Mayo Clin. Proc., July 1, 2009; 84(7): 643 - 662. [Abstract] [Full Text] [PDF]

				M. D. O'Neill, M. Wright, S. Knecht, P. Jais, M. Hocini, Y. Takahashi, A. Jonsson, F. Sacher, S. Matsuo, K. T. Lim, et al. Long-term follow-up of persistent atrial fibrillation ablation using termination as a procedural endpoint Eur. Heart J., May 1, 2009; 30(9): 1105 - 1112. [Abstract] [Full Text] [PDF]

				T. Rostock, D. Steven, B. Hoffmann, H. Servatius, I. Drewitz, K. Sydow, K. Mullerleile, R. Ventura, K. Wegscheider, T. Meinertz, et al. Chronic Atrial Fibrillation Is a Biatrial Arrhythmia: Data from Catheter Ablation of Chronic Atrial Fibrillation Aiming Arrhythmia Termination Using a Sequential Ablation Approach Circ Arrhythm Electrophysiol, December 1, 2008; 1(5): 344 - 353. [Abstract] [Full Text] [PDF]

				S. Knecht, M. Hocini, M. Wright, N. Lellouche, M. D. O'Neill, S. Matsuo, I. Nault, V. S. Chauhan, K. J. Makati, M. Bevilacqua, et al. Left atrial linear lesions are required for successful treatment of persistent atrial fibrillation Eur. Heart J., October 1, 2008; 29(19): 2359 - 2366. [Abstract] [Full Text] [PDF]

				M. Haissaguerre, M. Wright, M. Hocini, and P. Jais The Substrate Maintaining Persistent Atrial Fibrillation Circ Arrhythm Electrophysiol, April 1, 2008; 1(1): 2 - 5. [Full Text] [PDF]

				A. M. Patel, A. d'Avila, P. Neuzil, S. J. Kim, MSEE, T. Mela, J. P. Singh, J. N. Ruskin, and V. Y. Reddy Atrial Tachycardia After Ablation of Persistent Atrial Fibrillation: Identification of the Critical Isthmus With a Combination of Multielectrode Activation Mapping and Targeted Entrainment Mapping Circ Arrhythm Electrophysiol, April 1, 2008; 1(1): 14 - 22. [Abstract] [Full Text] [PDF]

				N.-W. Hsu, Y.-J. Lin, C.-T. Tai, T. Kao, S.-L. Chang, W. Wongcharoen, L.-W. Lo, A. R. Udyavar, Y.-F. Hu, H.-W. Tso, et al. Frequency analysis of the fibrillatory activity from surface ECG lead V1 and intracardiac recordings: implications for mapping of AF Europace, April 1, 2008; 10(4): 438 - 443. [Abstract] [Full Text] [PDF]

				Y. Takahashi, M. D. O'Neill, M. Hocini, R. Dubois, S. Matsuo, S. Knecht, S. Mahapatra, K.-T. Lim, P. Jais, A. Jonsson, et al. Characterization of electrograms associated with termination of chronic atrial fibrillation by catheter ablation. J. Am. Coll. Cardiol., March 11, 2008; 51(10): 1003 - 1010. [Abstract] [Full Text] [PDF]

				R. Arora, J. S. Ulphani, R. Villuendas, J. Ng, L. Harvey, S. Thordson, F. Inderyas, Y. Lu, D. Gordon, P. Denes, et al. Neural substrate for atrial fibrillation: implications for targeted parasympathetic blockade in the posterior left atrium Am J Physiol Heart Circ Physiol, January 1, 2008; 294(1): H134 - H144. [Abstract] [Full Text] [PDF]

				E. Pruvot, F. Jousset, P. Ruchat, J.-M. Vesin, Y. Prudat, T. Zerm, and M. Fromer Propagation velocity kinetics and repolarization alternans in a free-behaving sheep model of pacing-induced atrial fibrillation Europace, November 1, 2007; 9(suppl_6): vi83 - vi88. [Abstract] [Full Text] [PDF]

				M. D. O'Neill, P. Jais, M. Hocini, F. Sacher, G. J. Klein, J. Clementy, and M. Haissaguerre Catheter Ablation for Atrial Fibrillation Circulation, September 25, 2007; 116(13): 1515 - 1523. [Full Text] [PDF]

				H. Calkins, J. Brugada, D. L. Packer, R. Cappato, S.-A. Chen, H. J.G. Crijns, R. J. Damiano Jr, D. W. Davies, D. E. Haines, M. Haissaguerre, et al. HRS/EHRA/ECAS Expert Consensus Statement on Catheter and Surgical Ablation of Atrial Fibrillation: Recommendations for Personnel, Policy, Procedures and Follow-Up: A report of the Heart Rhythm Society (HRS) Task Force on Catheter and Surgical Ablation of Atrial Fibrillation Developed in partnership with the European Heart Rhythm Association (EHRA) and the European Cardiac Arrhythmia Society (ECAS); in collaboration with the American College of Cardiology (ACC), American Heart Association (AHA), and the Society of Thoracic Surgeons (STS). Endorsed and Approved by the governing bodies of the American College of Cardiology, the American Heart Association, the European Cardiac Arrhythmia Society, the European Heart Rhythm Association, the Society of Thoracic Surgeons, and the Heart Rhythm Society. Europace, June 1, 2007; 9(6): 335 - 379. [Full Text] [PDF]

				M. M. Scheinman and E. Keung The Year in Clinical Cardiac Electrophysiology J. Am. Coll. Cardiol., May 22, 2007; 49(20): 2061 - 2069. [Full Text] [PDF]

This Article Abstract Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Haïssaguerre, M. Articles by Jaïs, P. Search for Related Content PubMed PubMed Citation Articles by Haïssaguerre, M. Articles by Jaïs, P. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Hazardous Substances DB AMIODARONE HYDROCHLORIDE Medline Plus Health Information Atrial Fibrillation Related Collections Electrophysiology Ablation/ICD/surgery Arrhythmias, clinical electrophysiology, drugs